ACS Publications. Most Trusted. Most Cited. Most Read
Streptavidin in Antibody Pretargeting. 4. Site-Directed Mutation Provides Evidence That Both Arginine and Lysine Residues Are Involved in Kidney Localization
My Activity

Figure 1Loading Img
    Article

    Streptavidin in Antibody Pretargeting. 4. Site-Directed Mutation Provides Evidence That Both Arginine and Lysine Residues Are Involved in Kidney Localization
    Click to copy article linkArticle link copied!

    View Author Information
    Department of Radiation Oncology, University of Washington, Seattle, Washington 98195, and Fred Hutchinson Cancer Research Center, Seattle Washington 98109
    Other Access OptionsSupporting Information (1)

    Bioconjugate Chemistry

    Cite this: Bioconjugate Chem. 2004, 15, 6, 1454–1463
    Click to copy citationCitation copied!
    https://doi.org/10.1021/bc049869n
    Published October 26, 2004
    Copyright © 2004 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!

    The in vivo application of the protein streptavidin is limited by its propensity to localize to kidney, particularly when it is used as a carrier of radionuclides in Targeted Radionuclide Therapy. Our previous studies demonstrated that modification of recombinant “core” streptavidin (rSAv) by reaction of lysine residues with succinic anhydride and arginine residues with 1,2-cyclohexanedione dramatically decreases the kidney concentrations over that obtained with wild-type rSAv. In this investigation, we explored the role of lysine and arginine residues in kidney localization further by evaluating site-directed mutants of rSAv. In the five mutants studied, the four lysine residues found in each subunit of rSAv were replaced (independently) with an alanine (K80A, K121A, K132A, K134A), and a specific arginine was replaced with a histidine (R59H). The rSAv mutants were prepared from a “core” rSAv construct produced by expression in E. coli that had 124 amino acids (residues 13−136). Another rSAv construct that had 127 amino acids (residues 13−139), used in most of our previous studies, was also included for comparison. As an additional comparison, succinylated rSAv was prepared and evaluated. The rSAv proteins were radioiodinated and injected into athymic mice that were on a biotin-free diet for 5−7 days prior, and biodistribution data were obtained (for most proteins) at 1, 4, 24, and 48 h postinjection. The data obtained show large differences in kidney localizations of the wild-type rSAv and some rSAv mutants. The largest difference in the kidney concentration was noted for the rSAv-K134A mutant (1.90 ± 0.22%ID/g; 24 h pi) as compared to the wild-type rSAv (31.83 ± 5.26%ID/g) at the same time point. The concentration of rSAv-K134A mutant in kidney was slightly lower than that obtained with succinylated rSAv. At the 24 h time point, the kidney concentrations of the rSAv-R59H mutant (8.95 ± 2.94%ID/g) and the rSAv-K121A mutant (11.86 ± 1.61%ID/g) were lower than wild-type rSAv, but the rSAv mutants rSAv-K80A (27.95 ± 1.82%ID/g) and rSAv-K132A (32.50 ± 10.09%ID/g) were essentially the same. The data suggests that specific lysine and arginine residues are involved in kidney localization. Possible mechanisms for the observed kidney localization are discussed.

    Copyright © 2004 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    *

     Address correspondence to D. Scott Wilbur, Ph.D., Department of Radiation Oncology, University of Washington, Box 359658, 325 Ninth Ave., Seattle, WA 98104-2499. Phone:  206-341-5437. Fax: 206-341-5438. E-mail: [email protected].

     University of Washington.

    §

     Fred Hutchinson Cancer Research Center.

    Supporting Information Available

    Click to copy section linkSection link copied!

    Complete biodistribution data for wild-type rSAv, succinylated rSAv, and rSAv mutants (Tables S1−S8); size-exclusion HPLC and mass spectra for rSAv, rSAv mutants and succinylated rSAv (Figures S1−S16); and graphical representations of the proximity of paired lysines 121/134 and arginine 59 (Figures S17 and S18). This material is available free of charge via the Internet at http://pubs.acs.org/BC.

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!
    Citation Statements
    Explore this article's citation statements on scite.ai

    This article is cited by 9 publications.

    1. Rizia Bardhan, Wenxue Chen, Marc Bartels, Carlos Perez-Torres, Maria F. Botero, Robin Ward McAninch, Alejandro Contreras, Rachel Schiff, Robia G. Pautler, Naomi J. Halas, and Amit Joshi . Tracking of Multimodal Therapeutic Nanocomplexes Targeting Breast Cancer in Vivo. Nano Letters 2010, 10 (12) , 4920-4928. https://doi.org/10.1021/nl102889y
    2. Nianhuan Yao, Wenwu Xiao, Xiaobing Wang, Jan Marik, See Hyoung Park, Yoshikazu Takada and Kit S. Lam. Discovery of Targeting Ligands for Breast Cancer Cells Using the One-Bead One-Compound Combinatorial Method. Journal of Medicinal Chemistry 2009, 52 (1) , 126-133. https://doi.org/10.1021/jm801062d
    3. D. Scott Wilbur, Donald K. Hamlin, Ming-Kuan Chyan and Martin W. Brechbiel. Streptavidin in Antibody Pretargeting. 5. Chemical Modification of Recombinant Streptavidin for Labeling with the α-Particle-Emitting Radionuclides 213Bi and 211At. Bioconjugate Chemistry 2008, 19 (1) , 158-170. https://doi.org/10.1021/bc7002428
    4. John E. Cyr,, Daniel A. Pearson,, David M. Wilson,, Carol A. Nelson,, Mary Guaraldi,, Michael T. Azure,, John Lister-James,, Ludger M. Dinkelborg, and, Richard T. Dean. Somatostatin Receptor-Binding Peptides Suitable for Tumor Radiotherapy with Re-188 or Re-186. Chemistry and Initial Biological Studies. Journal of Medicinal Chemistry 2007, 50 (6) , 1354-1364. https://doi.org/10.1021/jm061290i
    5. Yawen Li, Ming-Kuan Chyan, Donald K. Hamlin, Holly Nguyen, Robert Vessella, D. Scott Wilbur. Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.. Nuclear Medicine and Biology 2021, 92 , 217-227. https://doi.org/10.1016/j.nucmedbio.2020.04.005
    6. Kelly Davis Orcutt, Margaret E. Ackerman, Maryelise Cieslewicz, Emmanuel Quiroz, Adrian L. Slusarczyk, John V. Frangioni, K. Dane Wittrup. A modular IgG-scFv bispecific antibody topology. Protein Engineering, Design and Selection 2010, 23 (4) , 221-228. https://doi.org/10.1093/protein/gzp077
    7. Jessica R. Newton-Northup, Said D. Figueroa, Thomas P. Quinn, Susan L. Deutscher. Bifunctional phage-based pretargeted imaging of human prostate carcinoma. Nuclear Medicine and Biology 2009, 36 (7) , 789-800. https://doi.org/10.1016/j.nucmedbio.2009.04.010
    8. Wenwu Xiao, Nianhuan Yao, Li Peng, Ruiwu Liu, Kit S. Lam. Near-infrared optical imaging in glioblastoma xenograft with ligand-targeting α3 integrin. European Journal of Nuclear Medicine and Molecular Imaging 2009, 36 (1) , 94-103. https://doi.org/10.1007/s00259-008-0920-0
    9. Li Peng, Ruiwu Liu, Jan Marik, Xiaobing Wang, Yoshikazu Takada, Kit S Lam. Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging. Nature Chemical Biology 2006, 2 (7) , 381-389. https://doi.org/10.1038/nchembio798

    Bioconjugate Chemistry

    Cite this: Bioconjugate Chem. 2004, 15, 6, 1454–1463
    Click to copy citationCitation copied!
    https://doi.org/10.1021/bc049869n
    Published October 26, 2004
    Copyright © 2004 American Chemical Society

    Article Views

    313

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.